España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Kura Oncology
KURA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$9.01
0.04
0.45%
At close: -
$9.10
0.09
1.00%
After Hours: Dec 20, 4:47 PM EDT
Get Report
Comment
Kura Oncology (KURA) Forecast
News
Earnings
Kura Oncology (KURA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Kura Oncology (NASDAQ:KURA) Stock
Kura Oncology Stock (NASDAQ: KURA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 09, 2024
Cantor Fitzgerald Reiterates Overweight on Ku...
Benzinga Newsdesk
Kura Oncology Provided Clinical Data From KOM...
Benzinga Newsdesk
Tuesday, November 26, 2024
Cantor Fitzgerald Reiterates Overweight on Ku...
Benzinga Newsdesk
Friday, November 22, 2024
Kura Oncology shares are trading higher. B of...
Benzinga Newsdesk
B of A Securities Maintains Buy on Kura Oncol...
Benzinga Newsdesk
Thursday, November 21, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
Avi Kapoor
Crude Oil Gains 1%; Deere Posts Better-Than-Expected Earnings
Avi Kapoor
TD Cowen Reiterates Buy on Kura Oncology
Benzinga Newsdesk
Kura Oncology shares are trading lower. The c...
Benzinga Newsdesk
Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings
Avi Kapoor
Jefferies Maintains Buy on Kura Oncology, Low...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Ku...
Benzinga Newsdesk
Maximus Reports Weak Earnings, Joins Atkore, PDD Holdings And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Kura Onc...
Benzinga Newsdesk
Wednesday, November 20, 2024
Kura Oncology, Kyowa Kirin Enter Global Strat...
Benzinga Newsdesk
Tuesday, November 19, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Monday, November 18, 2024
HC Wainwright & Co. Reiterates Buy on Kura On...
Benzinga Newsdesk
Wednesday, November 13, 2024
HC Wainwright & Co. Reiterates Buy on Kura On...
Benzinga Newsdesk
Thursday, November 07, 2024
Kura Oncology Q3 2024 GAAP EPS $(0.63), Inlin...
Benzinga Newsdesk
Wednesday, November 06, 2024
Cantor Fitzgerald Reiterates Overweight on Ku...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Kura On...
Benzinga Newsdesk
Tuesday, November 05, 2024
Kura Oncology To Present KOMET-007 Combinatio...
Benzinga Newsdesk
Thursday, October 24, 2024
UBS Initiates Coverage On Kura Oncology with ...
Benzinga Newsdesk
Kura Oncology Reported Preclinical Data Suppo...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Kura On...
Benzinga Newsdesk
Monday, October 14, 2024
This Caterpillar Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Avi Kapoor
Stifel Downgrades Kura Oncology to Hold, Lowe...
Benzinga Newsdesk
Tuesday, October 01, 2024
Reported Earlier, Kura's KOMET-001 Study in A...
Benzinga Newsdesk
Monday, September 09, 2024
Cantor Fitzgerald Reiterates Overweight on Ku...
Benzinga Newsdesk
Monday, August 12, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Kura On...
Benzinga Newsdesk
Friday, August 09, 2024
Cantor Fitzgerald Reiterates Overweight on Ku...
Benzinga Newsdesk
Wedbush Reiterates Outperform on Kura Oncolog...
Benzinga Newsdesk
Stifel Maintains Buy on Kura Oncology, Lowers...
Benzinga Newsdesk
Thursday, August 08, 2024
Kura Oncology Q2 2024 GAAP EPS $(0.59) Beats ...
Benzinga Newsdesk
Kura Oncology Announces FDA Clearance Of IND ...
Benzinga Newsdesk
Monday, June 24, 2024
HC Wainwright & Co. Reiterates Buy on Kura On...
Benzinga Newsdesk
Kura Oncology Presents Preclinical Data on Di...
Benzinga Newsdesk
Tuesday, June 18, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Thursday, May 16, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Reiterates Buy on Kura On...
Benzinga Newsdesk
Monday, May 06, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Friday, May 03, 2024
HC Wainwright & Co. Reiterates Buy on Kura On...
Benzinga Newsdesk
Wedbush Reiterates Outperform on Kura Oncolog...
Benzinga Newsdesk
Thursday, May 02, 2024
Kura Oncology shares are trading lower after ...
Benzinga Newsdesk
Kura Oncology Q1 2024 GAAP EPS $(0.59) Misses...
Benzinga Newsdesk
Monday, April 22, 2024
HC Wainwright & Co. Reiterates Buy on Kura On...
Benzinga Newsdesk
Kura Oncology shares are trading higher after...
Benzinga Newsdesk
Kura Oncology's Ziftomenib, Has Been Granted ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch